http://business.scotsman.com/finance.cfm?id=1354142007
Shareholders digest £18bn HBOS shock
BILL JAMIESON
THOSE who thought the 'great credit crunch' was a phenomenon confined to overexcited New York traders and a few never-heard-of German banks have had a huge surprise close to home.
It came in a brief and tersely worded announcement from the Edinburgh-based bank HBOS to the Stock Exchange last Tuesday that it was extending credit to a vast in-house debt-finance fund called Grampian Funding.
Especially eyebrow-raising was the size of this Jersey-registered fund: a whopping $37bn (£18bn).
Now, gigantic though it is, you will search in vain for any mention of Grampian in the 200-page HBOS annual report. There is no reference in the chairman or chief executive's statement, no section explaining its operations in the directors' report or any hint of its existence in the financial statement and balance sheet.
For the army of small HBOS shareholders, news that Grampian existed, never mind that it was the largest banking conduit in Europe and now needed financial assistance from its parent, came as a total shock, akin to discovering a face you thought you were familiar with had suddenly grown an enormous protrusion on the side of the head.
In the extraordinary market turbulence of recent weeks this exotic growth has suddenly appeared with all the sinister connotations of a malignant tumour. And £18bn for HBOS is some tumour. It represents 57% of the group's stock market capitalisation.


